What Qualifications Do You Need to Donate Plasma?

Plasma donation centers require you to meet a fairly specific checklist before they’ll hook you up to a machine. The typical baseline across most countries and collection organizations is that you must be between 18 and 65 years old, weigh at least about 110 pounds (50 kg), have veins suitable for the apheresis needle, and be in generally good health. But the real screening goes well beyond those basics, involving vital-signs checks, blood tests, infectious-disease screening, and a detailed health questionnaire that can turn up dozens of reasons for temporary or permanent deferral.

The Basic Physical Requirements

An international survey of 17 plasma collection organizations found that the standard donor profile requires registration between ages 18 and 65, a minimum weight of 50 kg, suitable veins for the apheresis procedure, and good general health.¹ In the United States, many commercial plasma centers set the upper age limit higher or leave it open-ended if you pass the physical exam. The minimum weight matters because your total blood volume needs to be large enough to safely tolerate having a portion of your plasma separated and removed.

Suitable veins sounds vague, but it’s a real barrier for some people. The needles used for plasmapheresis are larger than standard blood-draw needles, and the machine needs a reliable, accessible vein in your arm that can sustain a steady flow for roughly 30 to 45 minutes. If your veins are too small, scarred, or hard to access, a technician may defer you.

Vital Signs and Why Blood Pressure Is the Top Reason for Deferral

Before every single donation, staff will check your blood pressure, pulse, and temperature. This isn’t a formality. A large analysis of 255 U.S. source-plasma centers found that unacceptable blood pressure or pulse was the single most common reason donors were turned away, accounting for roughly 28% of all deferrals across three consecutive years.² That means if you show up with a reading that’s too high or too low, or your heart rate is outside the acceptable range, you’ll be sent home for that day.

The thresholds vary slightly between centers but generally align with FDA guidance. A systolic reading above 180 or below 90, or a diastolic above 100, will typically get you deferred. The same goes for a pulse outside roughly 50 to 100 beats per minute. These checks exist to protect you: plasma donation involves temporarily reducing your blood volume, and abnormal cardiovascular readings increase the risk of fainting or more serious events.

Blood Tests You Have to Pass

Your blood will be tested for several markers, some before every donation and others at intervals.

Hematocrit or hemoglobin: This measures the proportion of red blood cells in your blood. Most organizations assess it before each donation. Low hematocrit was the second most common deferral reason in the U.S. study mentioned above, making up about 14 to 16% of deferrals, and about 80% of those turned away for this reason were women.² If you’ve been anemic or have heavy periods, this is the test most likely to trip you up.
Total protein: All surveyed plasma organizations measure your total serum protein, particularly for new donors and periodically afterward.¹ If your protein levels are too low, the center won’t collect from you because losing more plasma would deplete you further. Low protein accounted for about 4% of deferrals in U.S. centers.²
Immunoglobulin G (IgG): About seven of the 17 internationally surveyed organizations also test IgG levels, mainly for new donors and on an annual basis.¹ IgG is a key antibody in your blood, and it’s one of the most valuable components extracted from donated plasma.
Protein electrophoresis and syphilis: In the U.S., these are performed at a donor’s first visit and every four months after that.²

Infectious Disease Screening

Every plasma donation is tested for HIV, hepatitis B, and hepatitis C. The screening involves both traditional antibody-based tests and nucleic acid testing (NAT), which looks for the actual genetic material of the viruses. NAT matters because it can detect infections during the “window period” before your immune system has made enough antibodies to show up on a standard test.³ This combination of testing methods makes the screening extremely sensitive. Samples are routinely screened for HIV-1 and HIV-2 antibodies and antigen, hepatitis C antibodies, and hepatitis B surface antigen, alongside the molecular screening.⁴

If any of these tests come back positive, you’ll be permanently deferred and the center is required to notify you. They’ll also typically discard the plasma and any previous donations still in quarantine. Plasma products go through additional viral inactivation and removal steps during manufacturing, but the front-end donor screening is the first and most important safety layer.⁵

The Health Questionnaire and Temporary Deferrals

Before every donation, you’ll answer a questionnaire covering recent travel, medications, illnesses, sexual behavior, and body modifications. Several of these can lead to temporary deferrals rather than outright disqualification.

Travel to areas where malaria is common is one of the more significant temporary deferrals. Depending on the country and the specific guidance, you may need to wait months or even a year after returning before you can donate. A German study found that among donors who should have been deferred, travel to malaria-endemic countries was the non-disclosed reason in about 0.7% of cases, suggesting some donors don’t always report it.⁶ Recent tattoos and piercings also carry deferral periods, typically a few months, because of the small risk of bloodborne infection from the procedure.

Mild illnesses cause a surprisingly high rate of non-disclosure. That same German study found that 3.3% of donors didn’t report a recent mild infection and 1.4% didn’t report a febrile illness.⁶ If you have a cold or a fever, you’re supposed to wait until you’ve recovered. This protects both you and the plasma supply, since donating while sick can worsen your symptoms and potentially contaminate the product.

Medications are another common source of temporary deferrals. Certain prescription drugs, particularly those that could affect the plasma recipient, will disqualify you for varying periods. Antibiotics usually mean you need to wait until you’ve finished the course and any underlying infection has cleared. Blood thinners and certain acne medications (like isotretinoin) carry longer deferral windows.

How Often You Can Donate and What “Qualified Donor” Means

In the United States, you can donate source plasma up to twice in a seven-day period, as long as at least 48 hours pass between sessions.² That adds up to a theoretical maximum of around 104 donations per year, which is far more frequent than whole-blood donation. European countries tend to be more conservative with their allowed frequency.

If you’re a first-time donor, U.S. centers treat your first visits differently. After two successful donations with acceptable test results, you’re classified as a “qualified donor.” If you go more than six months without donating, you’re treated as a new applicant donor again and have to restart the qualification process, including fresh screening tests.²

What Happens During the Actual Donation

Plasma donation uses a process called plasmapheresis, which is different from a standard blood draw. A machine draws your blood, separates the plasma from the red blood cells and other components using a centrifuge, collects the plasma in a bag, and returns everything else to your body through the same needle. The whole cycle takes roughly 30 to 45 minutes. Early automated machines could collect about 500 ml of plasma in an average of 30 minutes while keeping the donor continuously connected to their cells.⁷ Modern machines are faster and more efficient.

During the procedure, an anticoagulant called citrate is mixed with your blood to prevent clotting inside the machine. Citrate binds to calcium in your blood, which keeps the blood flowing smoothly through the tubing but can temporarily lower your calcium levels. This is why some donors feel tingling in their lips or fingertips, and it’s the basis for what staff sometimes call a “citrate reaction.”

Adverse Reactions and Who Is Most at Risk

Plasma donation is generally safe, but adverse reactions do happen. A single-center study reported adverse events in about 1.7% of all donations, with mild vasovagal reactions (lightheadedness, feeling faint) being the most common at about 1.2%. Bruising at the needle site came second at about 0.4%, and citrate-related symptoms occurred in roughly 0.3% of apheresis donations. Severe adverse reactions were very rare at about 0.02%, and none required hospitalization.⁸

Citrate reactions, specifically, can range from mild tingling to more concerning symptoms. The physiologic effects come from the temporary drop in blood calcium. In rare severe cases, the low calcium can affect muscle and heart function, potentially causing muscle spasms or cardiac rhythm changes.⁹ Staff are trained to watch for these symptoms and can slow the machine or give you oral calcium supplements if needed.

Younger and first-time donors have a notably higher risk of adverse events. One large Chinese study covering 27 plasma collection stations found that donors aged 18 to 25 had the highest reaction rate at about 2.6 per thousand donations, while donors aged 56 to 60 had the lowest at about 1.1 per thousand.¹⁰ Lower body weight and lower pre-donation blood pressure also predicted more reactions.⁸ If you’re young, light, and donating for the first time, eat well and hydrate thoroughly beforehand.

What Frequent Donation Does to Your Body Over Time

Donating plasma once or twice isn’t going to change much about your physiology. But if you’re donating at the maximum U.S. frequency of twice a week, your body is repeatedly losing proteins, antibodies, and other plasma components that take time to rebuild. Research has found that pools of plasma from high-frequency U.S. donors showed significantly lower levels of several key proteins compared to plasma from less frequent donors: total protein was about 9% lower, albumin about 15% lower, total IgG about 24% lower, and IgM roughly 28% lower.¹¹ The reductions correlated with how long each protein naturally takes to replenish in the body.

The long-term health implications of these protein drops are still debated. Reviews of the literature flag iron deficiency, protein and IgG loss, and even a contested association with certain malignancies as potential concerns for frequent long-term donors, though the evidence on some of these points is contradictory.¹² Other reported complications of frequent apheresis include citrate reactions, iron deficiency, and potential effects on bone health over the long term.¹³

Iron deficiency might seem surprising since your red blood cells are returned to you during plasmapheresis, unlike whole-blood donation. But small amounts of red cells are inevitably lost in the process, and the iron in plasma proteins themselves is also removed. Over dozens of donations per year, those losses add up. Some centers now offer iron supplements or monitor ferritin levels in regular donors, though this isn’t universal.

Why Pregnancy History Matters for Certain Plasma Products

If you’ve ever been pregnant, you may encounter additional screening at some centers, particularly for plasma destined for transfusion rather than fractionation. Pregnancy can trigger the production of HLA antibodies, which are immune proteins directed against tissues from other people. A study of more than 5,800 female donors found that about 24% of women who reported a prior pregnancy tested positive for HLA antibodies, and the rate increased with each additional pregnancy: from about 11% after one pregnancy to roughly 32% after four or more.¹⁴

These antibodies can cause a serious lung reaction called TRALI (transfusion-related acute lung injury) in recipients. As a result, many blood services now preferentially use plasma from male donors or from women who have never been pregnant for fresh-frozen plasma transfusion products. Asking about pregnancy history has been shown to be a reliable and cost-effective way to screen for this risk.¹⁵ For source plasma destined for fractionation into manufactured therapies, this is less of a concern because the processing steps break down those antibodies.

Paid Donation and What Your Plasma Becomes

In the U.S. and several other countries, plasma donors are compensated for their time. This is a key distinction from whole-blood donation, which is almost always volunteer-based. The economics are simple: the demand for plasma-derived therapies is enormous and growing, and volunteer systems have never been able to supply enough source plasma to meet it. A review of the ethics of paid versus voluntary donation found that the traditional stigma around paying donors has “little basis in evidence” and that compensation systems, when properly regulated, produce safe products.¹⁶

Your donated plasma ends up in a manufacturing pipeline that hasn’t fundamentally changed since the mid-twentieth century. The core process, based on ethanol fractionation, separates plasma into its component proteins. Modern refinements have improved the purity and recovery of key products, particularly immunoglobulin G (the antibody therapy used for immune deficiencies and autoimmune conditions), along with clotting factors for hemophilia and albumin for treating burns and liver disease.⁵ Over the decades, the fractionation industry expanded from producing mainly albumin to recovering a growing range of proteins, including coagulation factors, high-dose intravenous immunoglobulin, and newer products like alpha-1 protease inhibitor and protein C.¹⁷

Deferrals That Are Harder to Come Back From

Some deferral reasons make donors less likely to return and try again, even when the deferral is technically temporary. A military blood-donation study found that donors deferred for travel or residence in a malaria-endemic area were independently associated with a lower rate of returning to attempt re-donation, and they also took longer to come back.¹⁸ In practice, life circumstances that triggered the deferral often persist or recur, making the waiting period feel open-ended.

For everyday donors, the most frustrating deferrals tend to be the ones based on vital signs, since blood pressure and pulse can fluctuate from visit to visit. If you were turned away for a high reading, it may be worth checking whether caffeine, stress, or a rushed arrival played a role. Many regular donors learn to arrive early, sit calmly for a few minutes, and avoid coffee beforehand. For hematocrit deferrals, eating iron-rich foods and staying hydrated in the days before your appointment can make a measurable difference, particularly if you’re a woman who has been borderline before.

1
Transfusion Medicine Reviews. Plasma Donor Health Protection: Mapping Current Practices Through an International Survey
2
PubMed Central. Source plasma deferral trends: A 3-year analysis of 255 centers in the United States
3
PubMed. Nucleic acid testing to detect HBV infection in blood donors
4
PubMed Central. Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety
5
PubMed Central. Modern plasma fractionation
6
PubMed. Compliance of blood donors in Germany with non-sexual deferral criteria
7
PubMed. A new technique for the collection of plasma: machine plasmapheresis
8
Transfusion Medicine and Hemotherapy. Frequency of Adverse Events during Blood and Apheresis Donations: A Single-Center Study
9
PubMed Central. Anticoagulation techniques in apheresis: from heparin to citrate and beyond
10
Chinese Journal of Blood Transfusion. Adverse reactions of apheresis plasma donation in 27 domestic plasma donation stations
11
PubMed Central. Specific protein content of pools of plasma for fractionation from different sources: impact of frequency of donations
12
PubMed. Considerations on the number of plasma donations per donor per year: Pro
13
ISBT Science Series. Safe and sustainable plasmapheresis
14
PubMed Central. The Effect of Previous Pregnancy and Transfusion on HLA Alloimmunization in Blood Donors: Implications for a Transfusion Related Acute Lung Injury (TRALI) Risk Reduction Strategy
15
PubMed. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy
16
PubMed. Payment, compensation and replacement–the ethics and motivation of blood and plasma donation
17
PubMed. Plasma protein therapies: current and future perspectives
18
PubMed. Redonation Attempts Among Potential Donors With Pre-donation Deferrals in a Military Blood Donation Center